...
首页> 外文期刊>European Journal of Surgical Oncology: The Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology >The radiological excision of high risk and malignant lesions using the INTACT breast lesion excision system. A case series with an imaging follow up of at least 5 years
【24h】

The radiological excision of high risk and malignant lesions using the INTACT breast lesion excision system. A case series with an imaging follow up of at least 5 years

机译:使用INTACT乳腺病变切除系统对高风险和恶性病变进行放射学切除。影像随访至少5年的病例系列

获取原文
获取原文并翻译 | 示例

摘要

Purpose To evaluate the efficacy of a BLES procedure as a primary excisional biopsy rather than a surgical wide local excision for treatment of a high risk or a malignant lesion. Methods 41 patients underwent a BLES procedure in order to attempt to remove a small breast lesion using a 15 mm or 20 mm wand from August 2007 to January 2009. The lesions were either proven on prior core biopsy to show high risk or malignant pathology or were considered to be indeterminate or suspicious on ultrasound or mammography. The pathology was reviewed to include the final status of lesion excision. If margin involvement was demonstrated then a formal surgical excision was subsequently recommended. Follow up mammography or ultrasound was performed annually in patients following the final pathological diagnosis. Results 9 patients had a primary diagnosis of atypia (columnar cell change with atypia or atypical ductal hyperplasia (ADH)), 23 patients had ductal carcinoma in situ (DCIS) and 9 had an invasive carcinoma (IC) at the original BLES pathology. Clear BLES margins of >1 mm were obtained in 3/9 atypia lesions, 15/23 DCIS and 0/9 IC. 12/13 low grade DCIS were completely excised. Subsequent surgical margin excisions were undertaken in 20 patients. After at least 5 years of follow up (mean 66 months), 1 lesion had recurred on imaging. Conclusion A BLES excision has potential as an alternative technique to traditional surgical wide local excision in the management of certain small breast lesions with high risk and low grade malignant potential.
机译:目的评估BLES手术作为主要切除活检而不是外科手术局部切除术治疗高危或恶性病变的疗效。方法从2007年8月至2009年1月,对41例患者行BLES手术,以尝试使用15毫米或20毫米棒清除小乳腺病变。病灶经既往的活检证实为高危或恶性病理或在超声或乳房X线照片上被认为是不确定的或可疑的。对病理进行了回顾,以包括病变切除的最终状态。如果证实有边缘受累,则随后建议进行正式的手术切除。在最终病理诊断后,每年对患者进行随访乳房X光检查或超声检查。结果9例患者初步诊断为非典型性(非典型性非典型性肾小管细胞增生或非典型导管增生(ADH)),原发性BLES病理检查为23例导管原位癌(DCIS)和9例浸润性癌(IC)。在3/9非典型性病变,15/23 DCIS和0/9 IC中获得了大于1 mm的清晰BLES切缘。完全切除了12/13低品位DCIS。随后对20例患者进行了手术切缘切除术。至少随访5年(平均66个月),影像学检查发现有1处病灶复发。结论BLES切除术有可能替代传统的手术广泛局部切除术,用于治疗某些高风险,低恶性程度的小乳腺病变。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号